FABP5 human
SIGMA/SRP4505 - recombinant, expressed in E. coli
Synonym: E-FABP; Epidermal-type fatty acid-binding protein; Fatty acid-binding protein 5; Fatty acid-binding protein epidermal; Psoriasis-associated fatty acid-binding protein homolog
Product Type: Chemical
| biological source | human |
| form | lyophilized |
| impurities | endotoxin, tested |
| mol wt | ~16 kDa |
| NCBI accession no. | Q01469   |
| packaging | pkg of 100 μg |
| recombinant | expressed in E. coli |
| shipped in | wet ice |
| storage condition | avoid repeated freeze/thaw cycles |
| storage temp. | −20°C |
| UniProt accession no. | Q01469 |
| Biochem/physiol Actions: | FABP5 (fatty acid-binding protein 5) is involved in the pathogenesis of metabolic diseases. Absence of FABP-4 and -5 in mice protects them against diet-induced obesity, insulin resistance, type 2 diabetes, atherosclerosis and fatty liver disease. FABP5 is also associated with bladder, pancreas, prostate, breast cancers and glioblastoma. |
| General description: | FABPs (fatty acid-binding proteins) are small 14-15kDa intracellular cytosolic proteins. They are needed for the transport of lipids to specific areas in cells. The FABP5 gene is mapped to human chromosome 8q21. |
| Physical form: | Sterile filtered and Lyophilized without additives. |
| Reconstitution: | Centrifuge the vial prior to opening. Avoid freeze-thaw cycles. |
| Reconstitution: | Reconstitute in water to a concentration of 0.1-1.0 mg/mL. This solution can then be diluted into other aqueous buffers |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |